CN Stock MarketDetailed Quotes

000513 Livzon Pharmaceutical Group Inc.

Watchlist
  • 37.10
  • -0.90-2.37%
Not Open Jan 2 15:00 CST
33.81BMarket Cap16.70P/E (TTM)

Livzon Pharmaceutical Group Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Livzon Pharmaceutical Group Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--

Unlock Free Earnings Estimates

Livzon Pharmaceutical Group Inc. Earnings Reports

  • Livingstone Group: Report for the third quarter of 2024

    Oct 23, 2024 12:00 ET

  • Livzon Pharmaceutical Group Inc.: Half-year report for the year 2024.

    Aug 22, 2024 12:00 ET

  • Livzon Pharmaceutical Group Inc.: Summary of Half-Year Report in 2024.

    Aug 22, 2024 12:00 ET

  • Livingstone Group: Report for the first quarter of 2024

    Apr 23, 2024 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jan 2, 2025

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Price
    % Chg

    No Data

    Investment Theme Innovative Drugs
    Innovative Drugs
    Intraday-1.98%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday-2.04%
    Biomedical
    Biomedical
    Intraday-2.09%